SEI Investments’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

SEI Investments’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-280	Closed	-$7K	–	3427
2017 Q1	$7K	Sell	280 -6,506	-96%	-$163K	﹤0.01%	2535
2016 Q4	$218K	Buy	6,786 +810	+14%	+$34.5K	﹤0.01%	1765
2016 Q3	$299K	Hold	5,976	–	–	﹤0.01%	1577
2016 Q2	$253K	Buy	5,976 +2,838	+90%	+$155K	﹤0.01%	1495
2016 Q1	$206K	Buy	3,138 +935	+42%	+$48.8K	﹤0.01%	1521
2015 Q4	$137K	Sell	2,203 -5,870	-73%	-$413K	﹤0.01%	1638
2015 Q3	$540K	Buy	+8,073	New	+$659K	0.01%	1267

Other funds holding MACK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

SEI Investments's MACK Position: Q2 2017 in Review

SEI Investments sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2017, closing a stake of 280 shares — an estimated $7K sold.

SEI Investments first reported a position in MACK in Q3 2015 and held it in 7 quarters. The position peaked at $540K in Q3 2015. 119 funds tracked by Wall St. Rank hold MACK as of Q2 2017.

SEI Investments reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
SEI Investments sold 280 Merrimack Pharmaceuticals, Inc. shares in Q2 2017, an estimated $7K.
SEI Investments first reported a position in Merrimack Pharmaceuticals, Inc. in Q3 2015 and held it in 7 quarters.
SEI Investments's Merrimack Pharmaceuticals, Inc. position peaked at $540K in Q3 2015.
119 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2017.

Based on SEI Investments's 13F filing for Q2 2017, filed 31 Jul 2017.